Clinical trial
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing…
NCT00027963 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00027963 |
|---|---|
| Title | Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy |
| Official title | The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Pain |
| Intervention type | Drug, Other |
| Interventions | gabapentin, placebo |
| Enrollment | 100 |
| Start date | Feb 1, 2002 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: